modafinil has been researched along with nomifensine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Subbaiah, MAM | 1 |
| Haas, HL; Klyuch, BP; Korotkova, TM; Lin, JS; Ponomarenko, AA; Sergeeva, OA | 1 |
| Dopheide, MM; Miller, DK; Morgan, RE; Rodvelt, KR; Schachtman, TR | 1 |
| Buoli, M; Cahn, W; Serati, M | 1 |
3 review(s) available for modafinil and nomifensine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Triple Reuptake Inhibitors as Potential Therapeutics for Depression and Other Disorders: Design Paradigm and Developmental Challenges.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Drug Design; Humans; Selective Serotonin Reuptake Inhibitors | 2018 |
Alternative pharmacological strategies for adult ADHD treatment: a systematic review.
Topics: Adrenergic alpha-Agonists; Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Central Nervous System Stimulants; Desipramine; Dopamine Agents; Droxidopa; Drug Combinations; Duloxetine Hydrochloride; Guanfacine; Histamine Agents; Humans; Lisdexamfetamine Dimesylate; Lithium Compounds; Lobeline; Mecamylamine; Memantine; Modafinil; Morpholines; Nicotinic Agonists; Nicotinic Antagonists; Nomifensine; Paroxetine; Pyridines; Pyridoxine; Pyrrolidonecarboxylic Acid; Quinazolinones; Reboxetine; Venlafaxine Hydrochloride; Wakefulness-Promoting Agents | 2016 |
3 other study(ies) available for modafinil and nomifensine
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Modafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors.
Topics: Action Potentials; Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Radiation; Drug Interactions; Electric Stimulation; Gene Expression Regulation; Glutamate Decarboxylase; In Vitro Techniques; Isoenzymes; Male; Mesencephalon; Modafinil; Neural Inhibition; Neurons; Nomifensine; Rats; Rats, Wistar; Sulpiride | 2007 |
Modafinil evokes striatal [(3)H]dopamine release and alters the subjective properties of stimulants.
Topics: Amphetamine; Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Cocaine; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Male; Modafinil; Nicotine; Nomifensine; Rats; Rats, Sprague-Dawley | 2007 |